Effectiveness and Challenges of CLL Treatment in Real-World Patients
Photo Credit: Nemes Laszlo Ibrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor, is widely used for chronic lymphocytic leukemia (CLL) due to its effectiveness and lower toxicity compared to chemoimmunotherapy. However, its use is frequently challenged by …